• Analytical method development, validation and stability indicating studies on finasteride and tamsulosin hydrochloride, 2008-10: Dr. V. P. Choudhari (Rs. 2.00 lakhs).

  • Formulation and Evaluation of Rapid disintegrating Tablets of Nifedipine, Diltiazem, 2009-12: Dr. Swati Jagdale (Rs. 3.00 lakhs)

  • Development and validation of analytical methods for antihypertensive drugs, 2009-12: Dr. B.S. Kuchekar (Rs. 3.00 lakhs).

  • Development and validation of stability indicating HPLC and bioanalytical methods for some drugs, 2009-12: Prof. A. S. Sutar (Rs. 2.00 lakhs).

 
  • Analytical method development of some drugs 2012-14: Prof. Y. A. Shete (Rs. 2.00 lakhs).

  • Isolation and Characterization of impurities from tablet dosage form, 2013-2015, Dr. B. S. Kuchekar, (Rs.1.90 lakh).

  • Anti-oxidant activity and cytotoxicity evaluation of coumarin derivatives, 2013-2015, Dr. A. R. Chabukswar (Rs.1.90 lakh).

  • Development of time dependent methylprednisolone colonic delivery system, 2013-2015, Dr. S. C. Jagdale (Rs.1.90 lakh).

  • Stability indicating, impurity profile study of Pharmaceuticals and synthesis, isolation and characterisation of important related impurities, 2014-16: Prof. G. B. Choudhari (Rs.1.60 Lakhs).

  • A study of hazardous chemicals in personal care (cosmetics) products, 2013-15: Prof A. S. Sutar. (Rs. 2.30 lakhs).

  • Isolation and Characterization of impurities from tablet dosage form, 2013-15: Dr. B.S. Kuchekar (Rs. 1.90 lakhs).

  • Extraction and isolation of phytoconstituents from Euphorbia ligularia roxb (Family: Euphorbiaceae) and standardization of plant extracts using these phyto constituents as marker compounds, 2013-2015, Dr. A. M. Baheti (Rs.2.10 lakh).

  • Fingerprint and stability method development for poyherbal formulation containing piperine, zingiberene, eugenol and gallic acid/embelin in single Ayurvedic proprietary formulation, 2013-15: Dr. V. P. Choudhari (Rs. 2.30 lakhs).

  • Development and validation of a biorelevant dissolution test for sustain release dosage forms of BCS class II drugs, 2013-2015, Dr. A. P. Kulkarni (Rs.2.70 lakh).

  • A study of hazardous chemicals in personal care (cosmetics) products, 2013-2015, Prof. A. S. Sutar (Rs.2.30 lakh).

  • Design, development and Evaluation of oral strip of eletriptan hydrobromide, 2013-2015, Prof. S. A. Polshettiwar (Rs.1.50 lakh).

  • Synthesis and biological evaluation of designed molecules, 2013-2015, Prof. R. V. Gadhave (Rs.2.70 lakh).

  • Synthesis and anti-depressant evaluation of 1, 3, 4 triazino indol derivatives, 2013-2015, Prof. B. U. Nagargoje (Rs.2.70 lakh).

  • Ayurvedic formulation of Tobacco, Capsicum and Pomegranate for enhanced pharmacological activities, 2014-2016, Prof. A. R. Shastri (Rs.1.40 lakh)

  • Molecular modeling, Synthesis and biological evaluation of some novel Quinoline derivatives, 2014-2016, Prof. P. V. Adsule (Rs.1.60 lakh).

  • Enhancement of solubility and dissolution rate of celecoxib using liquisolid compact technique, 2014-2016 Prof. C. D. Bobade (Rs.1.20 lakh).

  • Stability indicating impurity profile study of pharmaceuticals and synthesis, isolation and characterization of important related impurities, 2014-2016, Prof. G. B. Choudhari (Rs.1.60 lakh).

  • Antiurolithiatic activity of fractions of Indian medicinal plant extract in laboratory animals, 2016-2018, Dr. A. T. Pawar (Rs. 1.50 lakh).